Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial.
Zhong X, He P, Chen J, Yan X, Wei B, Zhang Z, Bu H, Li J, Tian T, Lv Q, Wang X, Li H, Wang J, Huang J, Suo J, Liu X, Zheng H, Luo T.
Zhong X, et al. Among authors: chen j.
Gland Surg. 2022 Jan;11(1):216-225. doi: 10.21037/gs-21-911.
Gland Surg. 2022.
PMID: 35242683
Free PMC article.